Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...
Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in Eli Lilly’s Wegovy and Novo Nordisk’s Ozempic has been resolved.
The FDA has determined that the nationwide shortage of semaglutide injection, used for both diabetes and weight loss, is resolved after more than two years of limited availability due to high demand.
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
The U.S. is in a severe flu season, and antiviral medications such as Tamiflu can help if you get sick—but it's not recommended for everyone. Here's what you need to know about the medication.
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...
The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Breakfast snack packs sold at Kroger and Meijer stores in Michigan have been recalled, the FDA announced. Here's what to know.
We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.
Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...
The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has ...
Elon Musk's DOGE team has slashed hundreds of jobs paid for by fees from banks and other forms of funding rather than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results